Displaying 141 - 160 of 1628
Amgen Inc. and Horizon Therapeutics plc, FTC v.
FTC Sues to Block Biopharmaceutical Giant Amgen from Acquisition That Would Entrench Monopoly Drugs Used to Treat Two Serious Illnesses
Statement Regarding the Termination of CalPortland Company’s Attempted Acquisition of Assets Owned by Rival Cement Producer Martin Marietta Materials, Inc.
FTC Sues to Stop the Potentially Illegal Integration of New Orleans Area Hospitals Over Failure to Follow Federal Reporting Law
Intercontinental Exchange, Inc. and Black Knight, Inc., FTC v.
FTC Staff Seeks Court Order Preventing ICE from Consummating its Acquisition of Rival Black Knight Pending Agency Administrative Challenge
FTC, Justice Department, and European Commission Hold Third U.S.- EU Joint Technology Competition Policy Dialogue
FTC Files Amicus Brief in Sage Chemical vs. Supernus Pharmaceutical Supporting Competition in the Market for Drug Used to Treat Advanced Parkinson’s Disease
FTC and Justice Department to Hold Annual Spring Enforcers Summit
FTC Acts to Block Deal Combining the Two Top Mortgage Loan Technology Providers
Joint Statement of Chair Khan, Commissioner Slaughter, Commissioner Wilson, and Commissioner Bedoya, Regarding Amazon.com, Inc.'s Acquisition of 1Life Healthcare, Inc.
Statement of Commissioner Alvaro M. Bedoya Joined by Commissioner Rebecca Kelly Slaughter Regarding Amazon.com, Inc.'s Acquisition of 1Life Healthcare, Inc.
Meta/Zuckerberg/Within, In the Matter of
The Federal Trade Commission authorized an administrative complaint against the proposed merger between virtual reality (VR) giant Meta and Within Unlimited, the VR studio that markets Supernatural, a leading VR fitness app. Formerly known as Facebook Inc., Meta sells the most widely used VR headset, operates a widely used VR app store, and already owns many popular VR apps. The agency alleges that Meta’s proposed acquisition of Within would harm competition and dampen innovation in the U.S. markets for fitness and dedicated-fitness VR apps.
Statement of Elizabeth Wilkins, Director of the FTC’s Office of Policy Planning, on the Decision of SUNY Upstate Medical University and Crouse Health System, Inc. to Drop Their Proposed Merger
Statement of Commissioner Rebecca Kelly Slaughter, Joined by Chair Lina M. Khan and Commissioner Alvaro M. Bedoya, Regarding the FY2021 HSR Annual Report
FTC, DOJ Issue Fiscal Year 2021 Hart Scott Rodino Premerger Notification Report
Statement of Commissioner Christine S. Wilson Regarding the FY2021 HSR Annual Report
Remarks by Holly Vedova at 12th Annual GCR Live: Law Leaders Global Conference
Displaying 141 - 160 of 1628